Chronic infection with the hepatitis C virus (HCV) may lead to hepatic fibrosis and eventually
cirrhosis, at which stage, patients have a substantial risk of liver failure, hepatocellular …

Interferon‐free combinations were registered in 2014 and 2015 for the treatment of chronic
HCV infection. As a result, real‐world experience has been gathered in the last year and this …

The rapid progress in the development of direct-acting antiviral agents for hepatitis C has
allowed the vast majority of patients to receive all oral therapy that will eliminate their virus …

Objective To assess impact of Direct Acting Antiviral (DAA) therapies for treatment of
Hepatitis C Virus (HCV) genotypes 1, 3 and 4 in a real-world cohort from India. Methods …

The approval of direct-acting antiviral agents that may be given orally in an interferon-free
regimen has greatly changed the landscape of treatment for hepatitis C virus (HCV) …

Introduction: Hepatitis C is a leading cause of cirrhosis and hepatocellular carcinoma
responsible for almost 700,000 deaths worldwide annually. Until 2014, management of HCV …

慢性丙型肝炎抗病毒治疗的革命性变化是近几年来直接抗病毒药物(direct-acting antiviral
agents, DAAs) 进入临床, 开辟了慢性丙型肝炎抗病毒治疗的新纪元. 以DAA …

Chronic hepatitis C (HCV) infection remains a major public health problem with many
infected individuals worldwide. The revolutionary discovery of highly effective direct-acting …

Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for
chronic hepatitis C virus infection: fact or fiction? - Liu - Translational Cancer Research Have a …

Neue Hepatitis-C-Therapien funktionieren in der Praxis Page 1 Auch in diesem Jahr gab es
auf dem Jahreskongress der European Association for the Study of the Liver (EASL) eine …